Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumors of bone. Denosumab is contraindicated in people with low blood calcium levels. The most common side effects are joint and muscle pain in the arms or legs.
1: Zheng BW, Zheng BY, Niu HQ, Yang YF, Zhu GQ, Li J, Zhang TL, Zou MX. Tumor Growth Rate in Spinal Giant Cell Tumors of Bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study. Neurosurgery. 2022 Nov 21. doi: 10.1227/neu.0000000000002237. Epub ahead of print. PMID: 36409294.
2: Giantini-Larsen AM, Chakravarthy VB, Barzilai O, Newman WC, Wexler L, Bilsky MH. The role of neoadjuvant denosumab in the treatment of aneurysmal bone cysts: a case series and review of the literature. J Neurosurg Pediatr. 2022 Sep 30:1-8. doi: 10.3171/2022.8.PEDS22314. Epub ahead of print. PMID: 36282899.
3: Wadiura LI, Butylina M, Reinprecht A, Aretin MB, Mischkulnig M, Gleiss A, Pietschmann P, Kerschan-Schindl K. Denosumab for Prevention of Acute Onset Immobilization-Induced Alterations of Bone Turnover: A Randomized Controlled Trial. J Bone Miner Res. 2022 Nov;37(11):2156-2164. doi: 10.1002/jbmr.4694. Epub 2022 Sep 23. PMID: 36056473.
4: Noh SH, Ha Y, Cho PG, Kim KN, Shin DA, Kim SH. The Effect of Denosumab and Risk Factors for Recurrence in Spinal Giant Cell Tumors: A Systematic Review and Meta-Analysis. Yonsei Med J. 2022 Sep;63(9):834-841. doi: 10.3349/ymj.2022.63.9.834. PMID: 36031783; PMCID: PMC9424782.
5: Tsuji Y, Fukuo Y, Kanemitsu T, Katayama Y, Yagi R, Hiramatsu R, Kameda M, Nonoguchi N, Furuse M, Kawabata S, Baba I, Takami T, Wanibuchi M. Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical Spine Encasing the Vertebral Artery: A Technical Case Report. Neurol Med Chir (Tokyo). 2022 Sep 15;62(9):438-443. doi: 10.2176/jns-nmc.2022-0158. Epub 2022 Aug 27. PMID: 36031352; PMCID: PMC9534568.
6: Khalid SI, Nunna RS, Smith JS, Shanker RM, Cherney AA, Thomson KB, Chilakapati S, Mehta AI, Adogwa O. The role of bone mineral density in adult spinal deformity patients undergoing corrective surgery: a matched analysis. Acta Neurochir (Wien). 2022 Sep;164(9):2327-2335. doi: 10.1007/s00701-022-05317-4. Epub 2022 Aug 4. PMID: 35922723.
7: Mousavi SR, Rezvani A, Eghbal K, Motlagh MAS, Dehghanian AR, Taherpour S, Farrokhi M. Alternative approach to treatment of unusual site giant cell tumor at cervical spine: A case report and review of literature. J Craniovertebr Junction Spine. 2022 Apr-Jun;13(2):212-220. doi: 10.4103/jcvjs.jcvjs_45_22. Epub 2022 Jun 13. PMID: 35837426; PMCID: PMC9274672.
8: Anusitviwat C, Ruangchainikom M, Korwutthikulrangsri E, Sutipornpalangkul W. Total neurological recovery after surgical decompression and treatment with denosumab of large unresectable spinal giant cell tumour expanding to mediastinum. BMJ Case Rep. 2022 May 12;15(5):e248837. doi: 10.1136/bcr-2022-248837. PMID: 35550320; PMCID: PMC9109021.
9: Palmisciano P, Hunter M, Lokesh N, Bin Alamer O, Scalia G, Giammalva GR, Maugeri R, Iacopino DG, Umana GE, Haider AS. Aneurysmal bone cyst of the spine in adult patients: A systematic review and comparison of primary vs secondary lesions. J Clin Neurosci. 2022 Jun;100:15-22. doi: 10.1016/j.jocn.2022.03.040. Epub 2022 Apr 1. PMID: 35367732.
10: Palmisciano P, Ferini G, Chen AL, Balasubramanian K, Kharbat AF, Sagoo NS, Bin Alamer O, Scalia G, Umana GE, Aoun SG, Haider AS. Evaluating the Optimal Management of Inoperable Giant Cell Tumors of the Spine: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022 Feb 14;14(4):937. doi: 10.3390/cancers14040937. PMID: 35205687; PMCID: PMC8870612.
11: Wu YC, Chen S, Wu PL, Tsou HK, Wei JC. Regarding: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients. J Intern Med. 2022 Mar;291(3):384-385. doi: 10.1111/joim.13400. Epub 2021 Nov 14. PMID: 34779048.
12: Yaprak Bayrak B, Özcan E, Vural Ç, Emengen A, Çabuk B, Ceylan S. A single- center experience with giant cell tumors of sphenoid bone and clivus. Tumori. 2021 Dec;107(6):NP94-NP100. doi: 10.1177/03008916211024357. Epub 2021 Aug 10. PMID: 34374310.
13: Fiani B, Newhouse A, Sarhadi KJ, Arshad M, Soula M, Cathel A. Special Considerations to Improve Clinical Outcomes in Patients with Osteoporosis Undergoing Spine Surgery. Int J Spine Surg. 2021 Apr;15(2):386-401. doi: 10.14444/8050. Epub 2021 Apr 5. PMID: 33900998; PMCID: PMC8059385.
14: Müther M, Schwake M, Suero Molina E, Schroeteler J, Stummer W, Klingenhöfer M, Ewelt C. Multiprofessional Management of Giant Cell Tumors in the Cervical Spine: A Systematic Review. World Neurosurg. 2021 Jul;151:53-60. doi: 10.1016/j.wneu.2021.04.006. Epub 2021 Apr 12. PMID: 33857672.
15: Furuta T, Kubo T, Sakuda T, Saito T, Kurisu K, Muragaki Y, Adachi N. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study. Acta Radiol. 2022 Feb;63(2):176-181. doi: 10.1177/0284185121989515. Epub 2021 Jan 31. PMID: 33517664.
16: Tanikawa M, Yamada H, Sakata T, Mase M. Dosing interval adjustment of denosumab for the treatment of giant cell tumor of the sphenoid bone: A case report. Surg Neurol Int. 2020 Nov 6;11:370. doi: 10.25259/SNI_439_2020. PMID: 33408904; PMCID: PMC7771493.
17: Rajgor HD, James S, Botchu R, Grainger M, Czyz M. Should Denosumab or Radical Surgery Be Recommended for a Spinal Giant Cell Tumour in a Fertile Female? Cureus. 2020 Nov 17;12(11):e11526. doi: 10.7759/cureus.11526. PMID: 33354470; PMCID: PMC7746321.
18: Khalid SI, Nunna RS, Maasarani S, Belmont E, Deme P, Chilakapati S, Eldridge C, Singh R, Bagley CA, Adogwa O. Association of osteopenia and osteoporosis with higher rates of pseudarthrosis and revision surgery in adult patients undergoing single-level lumbar fusion. Neurosurg Focus. 2020 Aug;49(2):E6. doi: 10.3171/2020.5.FOCUS20289. PMID: 32738806.
19: Anderson PM, Scott J, Parsai S, Zahler S, Worley S, Shrikanthan S, Subbiah V, Murphy E. 223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy. ESMO Open. 2020 Apr;5(2):e000635. doi: 10.1136/esmoopen-2019-000635. PMID: 32303572; PMCID: PMC7199915.
20: Marques P, Appelman-Dijkstra NM, Gelderblom H, Kruit MC, van Furth WR, Pereira AM, Biermasz NR. Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone. Lancet Diabetes Endocrinol. 2020 Apr;8(4):348. doi: 10.1016/S2213-8587(20)30041-3. Epub 2020 Feb 11. PMID: 32059785.
21: Bilgetekin I, Mammadkhanli O, Basal FB, Kandemir O, Canbay S, Oksuzoglu B. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response. Anticancer Drugs. 2020 Jun;31(5):533-535. doi: 10.1097/CAD.0000000000000859. PMID: 31743134.
22: Gilani A, Kleinschmidt-DeMasters BK. Denosumab Therapy Obscures Histological Features of Giant Cell Tumor of Bone. J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1171-1173. doi: 10.1093/jnen/nlz100. PMID: 31665371.
23: Heinrich C, Gospodarev V, Kheradpour A, Zuppan C, Douglas CC, Minasian T. Benign Giant Cell Lesion of C1 Lateral Mass: A Case Report and Literature Review. Brain Sci. 2019 May 8;9(5):105. doi: 10.3390/brainsci9050105. PMID: 31071908; PMCID: PMC6562483.
24: Wu D, Gomes Lima CJ, Moreau SL, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. Improved Survival After Multimodal Approach with 131I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer. Thyroid. 2019 Jul;29(7):971-978. doi: 10.1089/thy.2018.0582. Epub 2019 May 30. PMID: 31017051.
25: Raheja R, Wolfish EB, Huded JM. Complications Encountered with Non-adherence to Regular Follow-up in the Long-term Medical Management of Hyperparathyroidism. Cureus. 2019 Jan 26;11(1):e3966. doi: 10.7759/cureus.3966. PMID: 30956918; PMCID: PMC6436886.
26: Nozawa A, Ozeki M, Hori T, Kato H, Ohe N, Fukao T. Fatal Progression of Gorham-Stout Disease with Skull Base Osteomyelitis and Lateral Medullary Syndrome. Intern Med. 2019 Jul 1;58(13):1929-1933. doi: 10.2169/internalmedicine.2118-18. Epub 2019 Feb 25. PMID: 30799352; PMCID: PMC6663530.
27: Jia Q, Chen G, Cao J, Yang X, Zhou Z, Wei H, Liu T, Xiao J. Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center. Spine J. 2019 Jul;19(7):1232-1241. doi: 10.1016/j.spinee.2019.02.011. Epub 2019 Feb 15. PMID: 30776487.
28: Oktay K, Guzel E, Simsek S, Guzel A. Giant cell tumor of the eleventh thoracic vertebra in a pediatric patient: an interesting case report and comprehensive literature review. Childs Nerv Syst. 2019 Mar;35(3):553-557. doi: 10.1007/s00381-018-3980-x. Epub 2018 Sep 26. PMID: 30259086.
29: Sekar A, Rudrappa S, Gopal S, Ghosal N, Gupta V, Ts L. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base. World Neurosurg. 2018 Nov;119:97-102. doi: 10.1016/j.wneu.2018.07.207. Epub 2018 Aug 1. PMID: 30075260.
30: Yip CM, Lee HP, Hsu SS, Chen YT. Left orbital roof giant cell tumor of bone: A case report. Surg Neurol Int. 2018 Jun 26;9:127. doi: 10.4103/sni.sni_467_17. PMID: 30034918; PMCID: PMC6034354.
31: Verspoor FGM, Mastboom MJL, Weijs WLJ, Koetsveld AC, Schreuder HWB, Flucke U. Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature. Int J Oral Maxillofac Surg. 2018 Oct;47(10):1288-1294. doi: 10.1016/j.ijom.2018.04.001. Epub 2018 Apr 27. PMID: 29709323.
32: Scotto di Carlo F, Divisato G, Iacoangeli M, Esposito T, Gianfrancesco F. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer. 2018 Apr 2;18(1):358. doi: 10.1186/s12885-018-4291-z. PMID: 29609578; PMCID: PMC5880014.
33: Nasser H, Dhanekula A, Abdulhak M, Mott M, Hammoud ZT. Giant Cell Tumor of Bone Presenting as Left Posteromedial Chest Wall Tumor. Ann Thorac Surg. 2018 Aug;106(2):e89-e91. doi: 10.1016/j.athoracsur.2018.02.053. Epub 2018 Mar 22. PMID: 29577929.
34: Zhang Y, Tang R. Denosumab treatment in postmenopausal women with osteoporosis. Lancet Diabetes Endocrinol. 2017 Oct;5(10):767. doi: 10.1016/S2213-8587(17)30286-3. PMID: 28938992.
35: de la Peña C, Guajardo JH, Gonzalez MF, Hinojosa MA, Cardona E. Cyberknife stereotactic radiosurgery and denosumab for giant cell tumour of the skull base: Case report. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):429-433. doi: 10.1016/j.rpor.2017.08.002. Epub 2017 Aug 30. PMID: 28883763; PMCID: PMC5581862.
36: Patibandla MR, Thotakura AK, Rao MN, Addagada GC, Nukavarapu MC, Panigrahi MK, Uppin S, Challa S, Dandamudi S. Clival giant cell tumor - A rare case report and review of literature with respect to current line of management. Asian J Neurosurg. 2017 Jan-Mar;12(1):78-81. doi: 10.4103/1793-5482.145112. PMID: 28413541; PMCID: PMC5379813.
37: Zhang Y, Ilaslan H, Bauer TW. Giant cell tumor of bone: imaging and histology changes after denosumab treatment : Comment on: von Borstel D, Taguibao RA, Strle NA, Burns JE. Giant cell tumor of the bone: Aggressive case initially treated with denosumab and intralesional surgery. Skeletal Radiol 2017;46:571-578. Skeletal Radiol. 2017 Jul;46(7):961-962. doi: 10.1007/s00256-017-2643-4. Epub 2017 Apr 7. PMID: 28389819.
38: Nicoli TK, Saat R, Kontio R, Piippo A, Tarkkanen M, Tarkkanen J, Jero J. Multidisciplinary Approach to Management of Temporal Bone Giant Cell Tumor. J Neurol Surg Rep. 2016 Jul;77(3):e144-e149. doi: 10.1055/s-0036-1592082. PMID: 28078198; PMCID: PMC5045306.
39: Kumar R, Meis JM, Amini B, McEnery KW, Madewell JE, Rhines LD, Benjamin RS. Giant Cell Tumor of Cervical Spine Presenting as Acute Asphyxia: Successful Surgical Resection After Down-Staging With Denosumab. Spine (Phila Pa 1976). 2017 May 15;42(10):E629-E632. doi: 10.1097/BRS.0000000000001951. PMID: 27792106.
40: Charest-Morin R, Boriani S, Fisher CG, Patel SR, Kawahara N, Mendel E, Bettegowda C, Rhines LD. Benign Tumors of the Spine: Has New Chemotherapy and Interventional Radiology Changed the Treatment Paradigm? Spine (Phila Pa 1976). 2016 Oct 15;41 Suppl 20:S178-S185. doi: 10.1097/BRS.0000000000001818. PMID: 27488295.
41: Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report. JBJS Case Connect. 2016 Jul-Sep;6(3):e74. doi: 10.2106/JBJS.CC.16.00015. PMID: 29252651.
42: Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration. World Neurosurg. 2016 Dec;96:47-57. doi: 10.1016/j.wneu.2016.05.086. Epub 2016 Jun 4. PMID: 27269210.
43: Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report. J Neurosurg. 2017 Feb;126(2):431-434. doi: 10.3171/2016.3.JNS152802. Epub 2016 May 13. PMID: 27177173.
44: Inoue A, Ohnishi T, Kohno S, Nishikawa M, Nishida N, Ohue S. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature. World Neurosurg. 2016 Jul;91:674.e1-6. doi: 10.1016/j.wneu.2016.04.054. Epub 2016 Apr 23. PMID: 27113403.
45: Elder BD, Sankey EW, Goodwin CR, Kosztowski TA, Lo SF, Bydon A, Wolinsky JP, Gokaslan ZL, Witham TF, Sciubba DM. Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors. Global Spine J. 2016 Feb;6(1):21-8. doi: 10.1055/s-0035-1555657. Epub 2015 Jun 15. PMID: 26835198; PMCID: PMC4733366.
46: Luksanapruksa P, Buchowski JM, Singhatanadgige W, Rose PC, Bumpass DB. Management of spinal giant cell tumors. Spine J. 2016 Feb;16(2):259-69. doi: 10.1016/j.spinee.2015.10.045. Epub 2015 Oct 30. PMID: 26523962.
47: Lam FC, Arle JE, Glazer PA, Kasper EM. Primary Extradural Tumors of the Spine - Case Review with Evidence-guided Management. Surg Neurol Int. 2014 Aug 28;5(Suppl 7):S373-5. doi: 10.4103/2152-7806.139673. PMID: 25289164; PMCID: PMC4173213.
48: Froehner M, Hölscher T, Hakenberg OW, Wirth MP. Treatment of bone metastases in urologic malignancies. Urol Int. 2014;93(3):249-56. doi: 10.1159/000365788. Epub 2014 Aug 7. PMID: 25115989.
49: Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E. Sustained long- term complete regression of a giant cell tumor of the spine after treatment with denosumab. Spine J. 2014 Jul 1;14(7):e15-21. doi: 10.1016/j.spinee.2014.02.019. Epub 2014 Feb 15. PMID: 24534393.